- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00344578
Clinical Outcomes After AcrySof® ReStor IOL Surgery in Faculty Practice at UTSW Medical Center at Dallas: A Retrospective Review
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The AcrySof® ReSTOR® intraocular lens (IOL) is the latest advance in vision surgery. This IOL has been uniquely designed to improve vision throughout the entire visual spectrum, up close, far away and everything in-between. Thus, giving cataract patients their best chance ever to function free of glasses.
The pre-operative and post-operative data from ReSTOR® IOL implant cataract surgeries will be analyzed to determine whether the desired outcome was achieved, i.e. excellent vision with no correction. Variables to be studied include patient age, gender, number of ReSTOR® IOL implants, ocular comorbidities, preoperative and postoperative corrected and uncorrected visual acuities, keratometry readings, and corneal topography readings. A patient survey will also be sent to patients having undergone the surgery to measure their level of satisfaction.
Project Goals: The ultimate outcome of this project is to learn more insight on the following:
- Visual acuity with and without correction of distance and near at 3-6 months
- Percent of patients requiring keratorefractive surgery
- Ocular comorbidity subgroup analysis
- Monocular implantation subanalysis (prior to LASIK)
- Comparison of post-op spherical equivalent to target refraction
- Posterior capsule opacity that may be treated with laser procedure known as a YAG laser capsulotomy?
- Subjective patient satisfaction
- Validated questionnaire assessing visual function and quality of life
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75390-8866
- Aston Ambulatory Care Center
-
Dallas, Texas, United States, 75390
- UTSW Medical Center at Dallas
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
All patients of any race and sex between the ages of 18-90 years of age who have undergone ReSTOR® IOL cataract surgery will be recruited in this retrospective project.
Exclusion Criteria:
Patients who underwent conventional IOL cataract extraction surgery
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
1)Visual acuity with and without correction of distance and near at 3-6 months
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Percent of patients requiring keratorefractive surgery
|
|
Ocular comorbidity subgroup analysis
|
|
Monocular implantation subanalysis (prior to LASIK)
|
|
Comparison of post-op spherical equivalent to target refraction
|
|
Posterior capsule opacity that may be treated with laser procedure known as a YAG laser capsulotomy?
|
|
Subjective patient satisfaction
|
|
Validated questionnaire assessing visual function and quality of life
|
Collaborators and Investigators
Investigators
- Principal Investigator: Adam Fedyk, MD, UTSW Medical Center at Dallas
- Study Director: Vinod Mootha, MD, UTSW Medical Center at Dallas
- Study Chair: James McCulley, MD, UTSW Medical Center at Dallas
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Fedyk001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.